NA
GMED icon

Navellier & Associates’s Globus Medical GMED Stock Holding History

Navellier & Associates’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-6,455
Closed -$455K – 314
2025
Q1 		$455K Sell
6,455
-2,851
-31% -$236K 0.06% 217
2024
Q4 		$770K Buy
+9,306
New +$734K 0.09% 194
2019
Q1 		– Sell
-82,254
Closed -$3.56M – 252
2018
Q4 		$3.56M Buy
+82,254
New +$4.1M 0.61% 32

Other funds holding GMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BAM
Burgundy Asset Management Toronto, Ontario, Canada $10.6B AUM 13.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
HRCM
Hawk Ridge Capital Management Los Angeles, California $2.75B AUM 20.09% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return

Navellier & Associates's GMED Position: Q2 2025 in Review

Navellier & Associates sold out of Globus Medical (GMED) in Q2 2025, closing a stake of 6,455 shares — an estimated $455K sold.

Navellier & Associates first reported a position in GMED in Q4 2018 and held it in 3 quarters. The position peaked at $3.56M in Q4 2018. 480 funds tracked by Wall St. Rank hold GMED as of Q2 2025.

  • Navellier & Associates reported no remaining Globus Medical position as of Q2 2025 after selling out during the quarter.
  • Navellier & Associates sold 6,455 Globus Medical shares in Q2 2025, an estimated $455K.
  • Navellier & Associates first reported a position in Globus Medical in Q4 2018 and held it in 3 quarters.
  • Navellier & Associates's Globus Medical position peaked at $3.56M in Q4 2018.
  • 480 funds tracked by Wall St. Rank held Globus Medical as of Q2 2025.

Based on Navellier & Associates's 13F filing for Q2 2025, filed 7 Aug 2025.